Three more POMs become pharmacy medicines
Three prescription medicines used to treat eczema and
dermatitis, fungal infections and migraine-related nausea and vomiting
become pharmacy only (P) medicines on 24 August 2001.
Clobetasone butyrate 0.05 per cent cream in 15g
packs becomes available for use in persons aged 12 years and over for
the short-term symptomatic treatment and control of eczema and dermatitis,
excluding seborrhoeic dermatitis. The antifungal fenticonazole nitrate
becomes available for external use (but in the case of vaginal use, only
for vaginal candidiasis) and packs of eight prochlorperazine maleate 3mg
buccal tablets become available to treat nausea and vomiting in people
aged 18 years and over with previously diagnosed migraine.
Other amendments to be made to the Prescription
Only Medicines (Human Use) Order 1997 include granting P status to:
- fluconazole for the treatment of candidal balanitis
(penile thrush) in men whose partners have vaginal candidiasis
- 30ml sprays of 1 per cent terbinafine for the
treatment of tinea corporis (ring worm), tinea cruris (jock itch) and
tinea pedis (athlete’s foot)
- hydrocortisone acetate equivalent to 1 per cent
hydrocortisone with miconazole nitrate for the treatment of athlete’s
foot and candidal intertrigo
- stannous fluoride 0.4 per cent dental gels for
the prevention and treatment of dental caries and decalcification of
the teeth
In addition, adrenaline for ophthalmic use is returned
to prescription control.
A number of recently introduced active ingredients
are also added to the POM Order. They are
- amisulpride
- balsalazide sodium
- benserazide
- brimonidine tartrate
- carbasalate calcium
- cefdinir
- cerivastatin sodium
- donepezil hydrochloride
- fexofenadine hydrochloride
- flutrimazole
- irbesartan
- levofloxacin
- mercaptamine bitartrate
- modafinil
- naratriptan hydrochloride
- pramipexole hydrochloride
- reboxetine mesilate
- sertindole
- temocapril hydrochloride
- testosterone
- valsartan
Back to Top
|
